Checkpoint inhibitors are a class of drugs that help the bodyâs immune system recognize and attack cancer cells. These inhibitors work by blocking the proteins that prevent immune cells, particularly T-cells, from attacking cancer cells. By inhibiting these checkpoint proteins, such as PD-1 and CTLA-4, the immune system can more effectively target and destroy cancerous cells.
